Repeated H2O2 exposure drives cell cycle progression in an in vitro model of ulcerative colitis

Journal of Cellular and Molecular Medicine

Volumn 17, Issue 12, 2013, Pages 1619-1631

  Poehlmann, Angela ^a   Reissig, Kathrin ^a   Schönfeld, Peter ^a   Walluscheck, Diana ^a   Schinlauer, Antje ^a   Hartig, Roland ^a   Lessel, Wiebke ^a   Guenther, Thomas ^b   Silver, Andrew ^c   Roessner, Albert ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b ST MARK S HOSPITAL   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cell cycle progression; DNA damage checkpoint adaptation; Hydrogen peroxide; Ulcerative colitis

Indexed keywords

CASPASE; CYCLIN D2; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 1A; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR;

ARTICLE; BIOLOGICAL MODEL; CELL CYCLE; CELL CYCLE CHECKPOINT; CELL CYCLE PROGRESSION; CELL LINE; CELL PROLIFERATION; CONTACT INHIBITION; CYTOLOGY; DNA DAMAGE CHECKPOINT ADAPTATION; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; EPITHELIUM CELL; HUMAN; INTRACELLULAR SPACE; METABOLISM; PATHOLOGY; ULCERATIVE COLITIS;

CELL CYCLE PROGRESSION; DNA DAMAGE CHECKPOINT ADAPTATION; HYDROGEN PEROXIDE; ULCERATIVE COLITIS;

CASPASES; CELL CYCLE; CELL CYCLE CHECKPOINTS; CELL LINE; CELL PROLIFERATION; COLITIS, ULCERATIVE; CONTACT INHIBITION; CYCLIN D2; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; ENZYME ACTIVATION; EPITHELIAL CELLS; HUMANS; HYDROGEN PEROXIDE; INTRACELLULAR SPACE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; REACTIVE OXYGEN SPECIES; TRANSCRIPTION FACTORS;

EID: 84891155522     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12150     Document Type: Article

References (68)

1. Seril DN, Liao J, Yang GY, et al. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis. 2003; 24: 353-62.
2. Roessner A, Kuester D, Malfertheiner P, et al. Oxidative stress in ulcerative colitis-associated carcinogenesis. Pathol Res Pract. 2008; 204: 511-24.
3. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144: 646-74.
4. Rubin DC, Shaker A, Levin MS. Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immunol. 2012; 3: 107.
5. Grivennikov SI, Karin M. Inflammation and oncogenesis: a vicious connection. Curr Opin Genet Dev. 2010; 20: 65-71.
6. Shaked H, Hofseth LJ, Chumanevich A, et al. Chronic epithelial NF-kappaB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation. Proc Natl Acad Sci USA. 2012; 109: 14007-12.
7. Mangerich A, Knutson CG, Parry NM, et al. Infection-induced colitis in mice causes dynamic and tissue-specific changes in stress response and DNA damage leading to colon cancer. Proc Natl Acad Sci USA. 2012; 109: 1820-9.
8. Meira LB, Bugni JM, Green SL, et al. DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Invest. 2008; 118: 2516-25.
9. Poehlmann A, Reissig K, Just A, et al. Non-apoptotic function of caspases in a cellular model of hydrogen peroxide-associated colitis. J Cell Mol Med. 2013; 17: 901-13.
10. Furth EE, Gustafson KS, Dai CY, et al. Induction of the tumor-suppressor p16(INK4a) within regenerative epithelial crypts in ulcerative colitis. Neoplasia. 2006; 8: 429-36.
11. Araki Y, Sugihara H, Hattori T. In vitro effects of dextran sulfate sodium on a Caco-2 cell line and plausible mechanisms for dextran sulfate sodium-induced colitis. Oncol Rep. 2006; 16: 1357-62.
12. Araki Y, Bamba T, Mukaisho KI, et al. Dextran sulfate sodium administered orally is depolymerized in the stomach and induces cell cycle arrest plus apoptosis in the colon in early mouse colitis. Oncol Rep. 2012; 28: 1597-605.
13. Poehlmann A, Roessner A. Importance of DNA damage checkpoints in the pathogenesis of human cancers. Pathol Res Pract. 2010; 206: 591-601.
14. Finn K, Lowndes NF, Grenon M. Eukaryotic DNA damage checkpoint activation in response to double-strand breaks. Cell Mol Life Sci. 2012; 69: 1447-73.
15. Langerak P, Russell P. Regulatory networks integrating cell cycle control with DNA damage checkpoints and double-strand break repair. Philos Trans R Soc Lond B Biol Sci. 2011; 366: 3562-71.
16. Dmitrieva NI, Cai Q, Burg MB. Cells adapted to high NaCl have many DNA breaks and impaired DNA repair both in cell culture and in vivo. Proc Natl Acad Sci USA. 2004; 101: 2317-22.
17. Roy PK, Rashid F, Bragg J, et al. Role of the JNK signal transduction pathway in inflammatory bowel disease. World J Gastroenterol. 2008; 14: 200-2.
18. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature. 2001; 410: 37-40.
19. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell. 2000; 103: 239-52.
20. Lin A. Activation of the JNK signaling pathway: breaking the brake on apoptosis. BioEssays. 2003; 25: 17-24.
21. Bogoyevitch MA. The isoform-specific functions of the c-Jun N-terminal kinases (JNKs): differences revealed by gene targeting. BioEssays. 2006; 28: 923-34.
22. Karin M, Gallagher E. From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life. 2005; 57: 283-95.
23. Potapova O, Gorospe M, Dougherty RH, et al. Inhibition of c-Jun N-terminal kinase 2 expression suppresses growth and induces apoptosis of human tumor cells in a p53-dependent manner. Mol Cell Biol. 2000; 20: 1713-22.
24. Hussain SP, Amstad P, Raja K, et al. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res. 2000; 60: 3333-7.
25. Blum S, Pfeiffer A, Tromvoukis Y. Immortalized adult human colon epithelial cell line. 2001. US Patent 6, 194, 203 B1.
26. Herbst U, Fuchs JI, Teubner W, et al. Malignant transformation of human colon epithelial cells by benzo[c]phenanthrene dihydrodiolepoxides as well as 2-hydroxyamino-1-methyl-6-phenylimidazo[4, 5-b]pyridine. Toxicol Appl Pharmacol. 2006; 212: 136-45.
27. Habold C, Poehlmann A, Bajbouj K, et al. Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis. J Cell Mol Med. 2008; 12: 607-21.
28. Poehlmann A, Habold C, Walluscheck D, et al. Cutting edge: Chk1 directs senescence and mitotic catastrophe in recovery from G(2) checkpoint arrest. J Cell Mol Med. 2011; 15: 1528-41.
29. Liu Y, Dean DC. Tumor initiation via loss of cell contact inhibition versus Ras mutation: do all roads lead to EMT? Cell Cycle. 2010; 9: 897-900.
30. Seluanov A, Hine C, Azpurua J, et al. Hypersensitivity to contact inhibition provides a clue to cancer resistance of naked mole-rat. Proc Natl Acad Sci USA. 2009; 106: 19352-7.
31. Mates JM, Segura JA, Alonso FJ, et al. Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis. Arch Toxicol. 2008; 82: 273-99.
32. Lopez-Lazaro M. Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy. Cancer Lett. 2007; 252: 1-8.
33. Morton S, Davis RJ, McLaren A, et al. A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J. 2003; 22: 3876-86.
34. Saadeddin A, Babaei-Jadidi R, Spencer-Dene B, et al. The links between transcription, beta-catenin/JNK signaling, and carcinogenesis. Mol Cancer Res. 2009; 7: 1189-96.
35. Yochum GS, Cleland R, Goodman RH. A genome-wide screen for beta-catenin binding sites identifies a downstream enhancer element that controls c-Myc gene expression. Mol Cell Biol. 2008; 28: 7368-79.
36. Gutierrez-Uzquiza A, Arechederra M, Bragado P, et al. p38alpha mediates cell survival in response to oxidative stress via induction of antioxidant genes: effect on the p70S6K pathway. J Biol Chem. 2012; 287: 2632-42.
37. Meloche S, Pouyssegur J. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene. 2007; 26: 3227-39.
38. Assi K, Pillai R, Gomez-Munoz A, et al. The specific JNK inhibitor SP600125 targets tumour necrosis factor-alpha production and epithelial cell apoptosis in acute murine colitis. Immunology. 2006; 118: 112-21.
39. Reinecke K, Eminel S, Dierck F, et al. The JNK inhibitor XG-102 protects against TNBS-induced colitis. PLoS ONE. 2012; 7: e30985.
40. Kennedy NJ, Sluss HK, Jones SN, et al. Suppression of Ras-stimulated transformation by the JNK signal transduction pathway. Genes Dev. 2003; 17: 629-37.
41. Tong C, Yin Z, Song Z, et al. c-Jun NH2-terminal kinase 1 plays a critical role in intestinal homeostasis and tumor suppression. Am J Pathol. 2007; 171: 297-303.
42. Seki E, Brenner DA, Karin M. A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology. 2012; 143: 307-20.
43. Hui L, Zatloukal K, Scheuch H, et al. Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation. J Clin Invest. 2008; 118: 3943-53.
44. Schreiber M, Kolbus A, Piu F, et al. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev. 1999; 13: 607-19.
45. Poole AJ, Heap D, Carroll RE, et al. Tumor suppressor functions for the Cdk inhibitor p21 in the mouse colon. Oncogene. 2004; 23: 8128-34.
46. Gartel AL, Radhakrishnan SK. Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res. 2005; 65: 3980-5.
47. Wong NA, Mayer NJ, Anderson CE, et al. Cyclin D1 and p21 in ulcerative colitis-related inflammation and epithelial neoplasia: a study of aberrant expression and underlying mechanisms. Hum Pathol. 2003; 34: 580-8.
48. Ogino S, Kawasaki T, Kirkner GJ, et al. Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer. J Pathol. 2006; 210: 147-54.
49. Kawamata S, Matsuzaki K, Murata M, et al. Oncogenic Smad3 signaling induced by chronic inflammation is an early event in ulcerative colitis-associated carcinogenesis. Inflamm Bowel Dis. 2011; 17: 683-95.
50. Blonska M, Lin X. CARMA1-mediated NF-kappaB and JNK activation in lymphocytes. Immunol Rev. 2009; 228: 199-211.
51. Sabapathy K, Hochedlinger K, Nam SY, et al. Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Mol Cell. 2004; 15: 713-25.
52. Healy S, Khan P, Davie JR. Immediate early response genes and cell transformation. Pharmacol Ther. 2013; 137: 64-77.
53. Ouwens DM, de Ruiter ND, van der Zon GC, et al. Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38. EMBO J. 2002; 21: 3782-93.
54. Wisdom R, Johnson RS, Moore C. c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J. 1999; 18: 188-97.
55. Angel P, Hattori K, Smeal T, et al. The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell. 1988; 55: 875-85.
56. Johnson R, Spiegelman B, Hanahan D, et al. Cellular transformation and malignancy induced by ras require c-jun. Mol Cell Biol. 1996; 16: 4504-11.
57. Eferl R, Ricci R, Kenner L, et al. Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell. 2003; 112: 181-92.
58. Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol. 2002; 4: E131-6.
59. Shaulian E, Schreiber M, Piu F, et al. The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest. Cell. 2000; 103: 897-907.
60. Walluscheck D, Poehlmann A, Hartig R, et al. ATF2 knockdown reinforces oxidative stress-induced apoptosis in TE7 cancer cells. J Cell Mol Med. 2013; 17: 976-88.
61. Brentnall TA, Pan S, Bronner MP, et al. Proteins that underlie neoplastic progression of ulcerative colitis. Proteomics Clin Appl.
62. Chakilam S, Gandesiri M, Rau TT, et al. Death-associated protein kinase controls STAT3 activity in intestinal epithelial cells. Am J Pathol. 2013; 182: 1005-20.
63. Wierstra I. Sp1: emerging roles-beyond constitutive activation of TATA-less housekeeping genes. Biochem Biophys Res Commun. 2008; 372: 1-13.
64. van Dekken H, Wink JC, Vissers KJ, et al. Wnt pathway-related gene expression during malignant progression in ulcerative colitis. Acta Histochem. 2007; 109: 266-72.
65. Cole AM, Myant K, Reed KR, et al. Cyclin D2-cyclin-dependent kinase 4/6 is required for efficient proliferation and tumorigenesis following Apc loss. Cancer Res. 2010; 70: 8149-58.
66. 2 metabolism in skeletal muscle mitochondria. FEBS Lett. 2013; 587: 1799-804.
67. Gillies RJ, Martinez-Zaguilan R, Martinez GM, et al. Tumorigenic 3T3 cells maintain an alkaline intracellular pH under physiological conditions. Proc Natl Acad Sci USA. 1990; 87: 7414-8.
68. Terzic J, Grivennikov S, Karin E, et al. Inflammation and colon cancer. Gastroenterology. 2010; 138: 2101-14.